probenecid has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Taylor, CP; Vartanian, MG | 1 |
Hansen, KT | 1 |
Löscher, W; Löschmann, PA; Richter, A | 1 |
3 other study(ies) available for probenecid and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
Article | Year |
---|---|
Probenecid pretreatment enhances anticonvulsant action of NBQX in mice.
Topics: Animals; Anticonvulsants; Ataxia; Drug Synergism; Injections, Intravenous; Male; Mice; Motor Activity; Probenecid; Quinoxalines; Seizures | 1992 |
Hepatic uptake and biliary excretion of the neuroprotectant 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo-(F)-quinoxaline in rat liver. Involvement of an organic anion transport system.
Topics: Animals; Bile; Biological Transport; Dose-Response Relationship, Drug; Liver; Male; Perfusion; Probenecid; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1995 |
The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia.
Topics: Animals; Cricetinae; Dystonia; Electric Stimulation; Excitatory Amino Acid Antagonists; Female; Injections, Intraperitoneal; Male; Mesocricetus; Probenecid; Quinoxalines; Receptors, AMPA; Solutions; Suspensions | 1993 |